Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description

BMC Cardiovascular Disorders

Hein de Vries²  Freek WA Verheugt¹  Aart Mudde³  Lilian Lechner³  Catherine Bolman³  Nadine Berndt³ 

[1] Department of Cardiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands;Department of Health Promotion, Faculty of Health, Medicine and Life Sciences, and School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands;Department of Psychology, Open University of the Netherlands, Heerlen, The Netherlands

关键词: Cost-effectiveness study;    Nicotine replacement therapy;    Telephone counselling;    Face-to-face counselling;    Smoking cessation;    Coronary heart disease;   

Others  :  1085032
DOI  :  10.1186/1471-2261-12-33

 received in 2012-02-16, accepted in 2012-03-21,  发布年份 2012

【 摘 要 】

Background

There is no more effective intervention for secondary prevention of coronary heart disease than smoking cessation. Yet, evidence about the (cost-)effectiveness of smoking cessation treatment methods for cardiac inpatients that also suit nursing practice is scarce. This protocol describes the design of a study on the (cost-)effectiveness of two intensive smoking cessation interventions for hospitalised cardiac patients as well as first results on the inclusion rates and the characteristics of the study population.

Methods/design

An experimental study design is used in eight cardiac wards of hospitals throughout the Netherlands to assess the (cost-)effectiveness of two intensive smoking cessation counselling methods both combined with nicotine replacement therapy. Randomization is conducted at the ward level (cross-over). Baseline and follow-up measurements after six and 12 months are obtained. Upon admission to the cardiac ward, nurses assess patients’ smoking behaviour, ensure a quit advice and subsequently refer patients for either telephone counselling or face-to-face counselling. The counselling interventions have a comparable structure and content but differ in provider and delivery method, and in duration. Both counselling interventions are compared with a control group receiving no additional treatment beyond the usual care. Between December 2009 and June 2011, 245 cardiac patients who smoked prior to hospitalisation were included in the usual care group, 223 in the telephone counselling group and 157 in the face-to-face counselling group. Patients are predominantly male and have a mean age of 57 years. Acute coronary syndrome is the most frequently reported admission diagnosis. The ultimate goal of the study is to assess the effects of the interventions on smoking abstinence and their cost-effectiveness. Telephone counselling is expected to be more (cost-)effective in highly motivated patients and patients with high SES, whereas face-to-face counselling is expected to be more (cost-)effective in less motivated patients and patients with low SES.

Discussion

This study examines two intensive smoking cessation interventions for cardiac patients using a multi-centre trial with eight cardiac wards. Although not all eligible patients could be included and the distribution of patients is skewed in the different groups, the results will be able to provide valuable insight into effects and costs of counselling interventions varying in delivery mode and intensity, also concerning subgroups.

Trial registration

Dutch Trial Register NTR2144

【 授权许可】

   
2012 Berndt et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]WHO: WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER package. World Health Organization, Geneva; 2008.
• [2]De Hollander EAM, Hoeymans N, Melse JM, Van Oers JAM, Polder JJ: Zorg voor Gezondheid: Volksgezondheid Toekomst Verkenning 2006. RIVM, Bilthoven; 2007.
• [3]Shah AM, Pfeffer MA, Hartley LH, Moye LA, Gersh BJ, Rutherford JD, Lamas GA, Rouleau JL, Braunwald E, Solomon SD: Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction. Am J Cardiol 2010, 106(7):911-916.
• [4]Van Spall HG, Chong A, Tu JV: Inpatient smoking-cessation counseling and all-cause mortality in patients with acute myocardial infarction. Am Heart J 2007, 154(2):213-220.
• [5]Critchley JA, Capewell S: Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003, 290(1):86-97.
• [6]Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE: Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007, 131(2):446-452.
• [7]Berndt NC, Bolman C, Mudde AN, Verheugt F, De Vries H, Lechner L: Risk groups and predictors of short-term smoking abstinence in patients with coronary heart disease. Heart Lung 2012, 41(4):332-343.
• [8]Scholte op Reimer W, De Swart E, De Bacquer D, Pyörälä K, Keil U, Heidrich J, Deckers JW, Kotseva K, Wood D, Boersma E: Smoking behaviour in European patients with established coronary heart disease. Eur Heart J 2006, 27:35-41.
• [9]Costa ML, Cohen JE, Chaiton MO, Ip D, McDonald P, Ferrence R: “Hardcore” definitions and their application to a population-based sample of smokers. Nicotine Tob Res 2010, 12(8):860-864.
• [10]Bolman C, de Vries H, van Breukelen G: A minimal-contact intervention for cardiac inpatients: long-term effects on smoking cessation. Prev Med 2002, 35(2):181-192.
• [11]Rigotti NA, Munafo MR, Stead LF: Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med 2008, 168(18):1950-1960.
• [12]Rice VH, Stead L: Nursing intervention and smoking cessation: meta-analysis update. Heart Lung 2006, 35(3):147-163.
• [13]Feenstra TL, Van Baal PHM, Hoogenveen RT, Vijgen SMC, Stolk E, Bemelmans WJE: Cost-effectiveness of interventions to reduce tobacco smoking in the Netherlands. In An application of the RIVM Chronic Disease Model. RIVM, Bilthoven; 2005.
• [14]Van Baal PHM, Vijgen SMC, Bemelmans WJE, Hoogenveen RT, Feenstra TL: Potential health benefits and cost effectiveness of tobacco tax increases and school intervention programs targeted at adolescents in the Netherlands. RIVM, Bilthoven; 2005.
• [15]CBO:: Dutch Institute for Health care: Guideline Treatment of Tobacco Dependence. Alphen aan den Rijn: Van Zuiden Communications; 2009.
• [16]Gordon L, Graves N, Hawkes A, Eakin E: A review of the cost-effectiveness of face-to-face behavioural interventions for smoking, physical activity, diet and alcohol. Chronic Illn 2007, 3(2):101-129.
• [17]Feenstra TL, Hamberg-van Reenen HH, Hoogenveen RT, Rutten-van Molken MP: Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health 2005, 8(3):178-190.
• [18]Quist-Paulsen P, Lydersen S, Bakke PS, Gallefoss F: Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease. Eur J Cardiovasc Prev Rehabil 2006, 13(2):274-280.
• [19]Ladapo JA, Jaffer FA, Weinstein MC, Froelicher ES: Projected cost-effectiveness of smoking cessation interventions in patients hospitalized with myocardial infarction. Arch Intern Med 2011, 171(1):39-45.
• [20]Segaar D: Adoption and implementation of smoking cessation support in health care. Maastricht University, Maastricht; 2006.
• [21]Bolman C, de Vries H, Mesters I: Factors determining cardiac nurses’ intentions to continue using a smoking cessation protocol. Heart Lung 2002, 31(1):15-24.
• [22]Segaar D, Willemsen MC, Bolman C, De Vries H: Nurse adherence to a minimal-contact smoking cessation intervention on cardiac wards. Res Nurs Health 2007, 30(4):429-444.
• [23]Segaar D, Bolman C, Willemsen MC, Vries H: Determinants of adoption of cognitive behavioral interventions in a hospital setting: example of a minimal-contact smoking cessation intervention for cardiology wards. Patient Educ Couns 2006, 61(2):262-271.
• [24]Sarna L, Bialous SA, Wells M, Kotlerman J, Wewers ME, Froelicher ES: Frequency of nurses’ smoking cessation interventions: report from a national survey. J Clin Nurs 2009, 18(14):2066-2077.
• [25]Hennrikus DJ, Lando HA, McCarty MC, Klevan D, Holtan N, Huebsch JA, Jestus S, Pentel PR, Pine D, Sullivan S, et al.: The TEAM project: the effectiveness of smoking cessation intervention with hospital patients. Prev Med 2005, 40(3):249-258.
• [26]Wetta-Hall R, Ablah E, Frazier LM, Molgaard C, Berry M, Good M: Factors influencing nurses’ smoking cessation assessment and counseling practices. J Addict Nurs 2005, 16(3):131-135.
• [27]Kotz D, van Litsenburg W, van Duurling R, van Schayck CP, Wesseling GJ: Smoking cessation treatment by Dutch respiratory nurses: reported practice, attitudes and perceived effectiveness. Patient Educ Couns 2008, 70(1):40-49.
• [28]Rigotti NA: Helping smokers with cardiac disease to abstain from tobacco after a stay in hospital. Cmaj 2009, 180(13):1283-1284.
• [29]Smith PM, Burgess E: Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial. Cmaj 2009, 180(13):1297-1303.
• [30]Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, et al.: Treating Tobacco Use and Dependence: 2008 Update. Department of Health and Human Services, U.S; 2008.
• [31]Stead LF, Perera R, Bullen C, Mant D, Lancaster T: Nicotine replacement therapy for smoking cessation. Cochrane database of systematic reviews (Online) 2008, (1):-146.
• [32]Lancaster T, Stead LF: Individual behavioural counselling for smoking cessation. Cochrane database of systematic reviews (Online) 2005, 180(2):-1292.
• [33]Stead LF, Perera R, Lancaster T: Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial. Cmaj 2006, 3:-2850.
• [34]Freund M, Campbell E, Paul C, McElduff P, Walsh RA, Sakrouge R, Wiggers J, Knight J: Smoking care provision in hospitals: a review of prevalence. Nicotine Tob Res 2008, 10(5):757-774.
• [35]Barth J, Critchley J, Bengel J: Psychosocial interventions for smoking cessation in patients with coronary heart disease. Cochrane database of systematic reviews (Online) 2008, (1):-6886.
• [36]Kotz D, Wagena EJ, Wesseling G: Smoking cessation practices of Dutch general practitioners, cardiologists, and lung physicians. Respir Med 2007, 101(3):568-573.
• [37]Quist-Paulsen P, Gallefoss F: Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease. BMJ 2003, 327(7426):1254-1257.
• [38]Heckman CJ, Egleston BL, Hofmann MT: Efficacy of motivational interviewing for smoking cessation: a systematic review and meta-analysis. Tob Control 2010., 19(5)
• [39]Soria R, Legido A, Escolano C, Lopez Yeste A, Montoya J: A randomised controlled trial of motivational interviewing for smoking cessation. Br J Gen Pract 2006, 56(531):768-774.
• [40]Pedersen SS, Deckers JW, van Os F, Erdman RAM: A multifactorial smoking cessation programme for patients with coronary artery disease: experiences and preliminary results. Neth Heart J 2002, 10:48-53.
• [41]Perez GH, Nicolau JC, Romano BW, Laranjeira R: Depression: a predictor of smoking relapse in a 6-month follow-up after hospitalization for acute coronary syndrome. Eur J Cardiovasc Prev Rehabil 2008, 15(1):89-94.
• [42]Thorndike AN, Regan S, McKool K, Pasternak RC, Swartz S, Torres-Finnerty N, Rigotti NA: Depressive symptoms and smoking cessation after hospitalization for cardiovascular disease. Arch Intern Med 2008, 168(2):186-191.
• [43]Kuhl EA, Fauerbach JA, Bush DE, Ziegelstein RC: Relation of anxiety and adherence to risk-reducing recommendations following myocardial infarction. Am J Cardiol 2009, 103(12):1629-1634.
• [44]Kawachi I, Sparrow D, Vokonas PS, Weiss ST: Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 1994, 90(5):2225-2229.
• [45]Pedersen SS, Lemos PA, van Vooren PR, Liu TK, Daemen J, Erdman RA, Smits PC, Serruys PW, van Domburg RT: Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J Am Coll Cardiol 2004, 44(5):997-1001.
• [46]Reid RD, Pipe AL, Quinlan B: Promoting smoking cessation during hospitalization for coronary artery disease. Can J Cardiol 2006, 22(9):775-780.
• [47]Narsavage G, Idemoto BK: Smoking cessation interventions for hospitalized patients with cardio-pulmonary disorders. Online J Issues Nurs 2003, 8(2):8.
• [48]Boyle RG, Solberg LI, Asche SE, Boucher JL, Pronk NP, Jensen CJ: Offering telephone counseling to smokers using pharmacotherapy. Nicotine Tob Res 2005, 7(Suppl 1):S19-S27.
• [49]Solomon LJ, Marcy TW, Howe KD, Skelly JM, Reinier K, Flynn BS: Does extended proactive telephone support increase smoking cessation among low-income women using nicotine patches? Prev Med 2005, 40(3):306-313.
• [50]McRobbie H, Hajek P: Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction 2001, 96(11):1547-1551.
• [51]Van Berkel TF, Boersma H, Roos-Hesselink JW, Erdman RA, Simoons ML: Impact of smoking cessation and smoking interventions in patients with coronary heart disease. A systematic review. Eur Heart J 1999, 20(24):1773-1782.
• [52]Rigotti NA, Arnsten JH, McKool KM, Wood-Reid KM, Singer DE, Pasternak RC: The use of nicotine-replacement therapy by hospitalized smokers. Am J Prev Med 1999, 17(4):255-259.
• [53]Smith PM, Burgess E: Intensive smoking cessation programs for hospitalized coronary patients: a proven intervention in need of implementation. JCOM 2009, 16(9):396-397.
• [54]Reid RD, Pipe AL, Quinlan B, Oda J: Interactive voice response telephony to promote smoking cessation in patients with heart disease: a pilot study. Patient Educ Couns 2007, 66(3):319-326.
• [55]Taylor CB, Houston Miller N, Killen JD, DeBusk RF: Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Annals Intern Med 1990, 113(2):118-123.
• [56]Huttunen-Lenz M, Song F, Poland F: Are psychoeducational smoking cessation interventions for coronary heart disease patients effective? Meta-analysis of interventions. Br J Health Psychol 2010, 15(4):749-777.
• [57]Lichtenstein E, Glasgow RE, Lando HA, Ossip-Klein DJ, Boles SM: Telephone counseling for smoking cessation: rationales and meta- analytic review of evidence. Health Educ Res 1996, 11(2):243-257.
• [58]Van Emst AJ: Persoonlijke coaching bij stoppen met roken: resultaten van een proces en effectstudie. Dutch Institute for a Smokefree Future, STIVORO, The Hague; 2007.
• [59]Fernandez E, Schiaffino A, Borrell C, Benach J, Ariza C, Ramon JM, Twose J, Nebot M, Kunst A: Social class, education, and smoking cessation: long-term follow-up of patients treated at a smoking cessation unit. Nicotine Tob Res 2006, 8(1):29-36.
• [60]Ramsay SE, Morris RW, Whincup PH, Papacosta O, Rumley A, Lennon L, Lowe G, Wannamethee SG: Socioeconomic inequalities in coronary heart disease risk in older age: contribution of established and novel coronary risk factors. J Thromb Haemost 2009, 7(11):1779-1786.
• [61]Schaap MM, Kunst AE: Monitoring of socio-economic inequalities in smoking: learning from the experiences of recent scientific studies. Public Health 2009, 123(2):103-109.
• [62]Reid JL, Hammond D, Boudreau C, Fong GT, Siahpush M: Socioeconomic disparities in quit intentions, quit attempts, and smoking abstinence among smokers in four western countries: findings from the International Tobacco Control Four Country Survey. Nicotine Tob Res 2010, 12(Suppl):S20-S33.
• [63]Hiscock R, Judge K, Bauld L: Social inequalities in quitting smoking: what factors mediate the relationship between socioeconomic position and smoking cessation? J Public Health 2011, 33(1):39-47.
• [64]Chouinard MC, Robichaud-Ekstrand S: The effectiveness of a nursing inpatient smoking cessation program in individuals with cardiovascular disease. Nurs Res 2005, 54(4):243-254.
• [65]Willemsen MC, et al.: De effectiviteit van stoppen-met-roken methoden die in Nederland beschikbaar zijn. Neth J Med 2003, 147:922-927.
• [66]Central Committee on Research involving Human Subjects: The review system in the Netherlands
• [67]Roozenbeek B, Maas AI, Lingsma HF, Butcher I, Lu J, Marmarou A, McHugh GS, Weir J, Murray GD, Steyerberg EW: Baseline characteristics and statistical power in randomized controlled trials: selection, prognostic targeting, or covariate adjustment? Crit Care Med 2009, 37(10):2683-2690.
• [68]International statistical classification of diseases and related health problems. 10th revision World Health Organization: 2007.
• [69]Berndt NC, Bolman C, de Vries H, Segaar D, van Boven I, Lechner L: Smoking Cessation Treatment Practices: Recommendations for Improved Adoption on Cardiology Wards. J Cardiov Nurs 2011.
• [70]Orleans CT, Woolf SH, Rothemich SF, Marks JS, Isham GJ: The top priority: building a better system for tobacco-cessation counseling. Am J Prev Med 2006, 31(1):103-106.
• [71]Gwaltney CJ, Metrik J, Kahler CW, Shiffman S: Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav 2009, 23(1):56-66.
• [72]Van Zundert RM, Ferguson SG, Shiffman S, Engels RC: Dynamic effects of self-efficacy on smoking lapses and relapse among adolescents. Health Psychol 2010, 29(3):246-254.
• [73]Lock EA, Latham GP: Building a practically useful theory of goal setting and task motivation. A 35-year odyssey. Am Psychol 2002, 57(9):705-717.
• [74]Marlatt GA, Donovan DM: Relapse prevention: maintainance strategies in the treatment of addictive behaviors. The Guilford Press, New York; 2005.
• [75]Prochaska JO, DiClemente CC: Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psych 1983, 51(3):390-395.
• [76]Thorndike AN, Rigotti NA: A tragic triad: coronary artery disease, nicotine addiction, and depression. Curr Opin Cardiol 2009, 24(5):447-453.
• [77]Janszky I, Ahnve S, Lundberg I, Hemmingsson T: Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol 2010, 56(1):31-37.
• [78]Denollet J, Pedersen SS: Anger, depression, and anxiety in cardiac patients: the complexity of individual differences in psychological risk. J Am Coll Cardiol 2009, 53(11):947-949.
• [79]Pedersen SS, Denollet J: Is type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. Curr Cardiol Rev 2006, 2:205-213.
• [80]Gerber Y, Koren-Morag N, Myers V, Benyamini Y, Goldbourt U, Drory Y: Long-term predictors of smoking cessation in a cohort of myocardial infarction survivors: a longitudinal study. Eur J Cardiovasc Prev Rehabil 2011, 18(3):533-541.
• [81]Quist-Paulsen P, Bakke PS, Gallefoss F: Predictors of smoking cessation in patients admitted for acute coronary heart disease. Eur J Cardiovasc Prev Rehabil 2005, 12(5):472-477.
• [82]Bolman C, de Vries H: Psycho-social determinants and motivational phases in smoking behavior of cardiac inpatients. Prev Med 1998, 27(5):738-747.
• [83]Berkel TFv, Vlugt MJvd, Boersma H: Characteristics of smokers and long-term changes in smoking behavior in consecutive patients with myocardial infarction. Prev Med 2000, 31(6):732-741.
• [84]Hughes JR, Stead LF, Lancaster T: Antidepressants for smoking cessation. Cochrane database of systematic reviews (Online) 2007, (1):-31.
• [85]Silagy C, Lancaster T, Stead L, Mant D, Fowler G: Nicotine replacement therapy for smoking cessation. Cochrane database of systematic reviews (Online) 2004, (3):-146.
• [86]Mudde AN, Willemsen MC, Kremers S, de Vries H: Meetinstrumenten voor onderzoek naar roken en stoppen met roken. STIVORO voor een rookvrije toekomst, Den Haag; 2006.
• [87]Velicer WF, Prochaska JO: A comparison of four self-report smoking cessation outcome measures. Addict Behav 2004, 29(1):51-60.
• [88]West R, Hajek P, Stead L, Stapleton J: Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005, 100(3):299-303.
• [89]Bolman C, de Vries H, van Breukelen G: Evaluation of a nurse-managed minimal-contact smoking cessation intervention for cardiac inpatients. Health Educ Res 2002, 17(1):99-116.
• [90]Cooke F, Bullen C, Whittaker R, McRobbie H, Chen MH, Walker N: Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res 2008, 10(4):607-612.
• [91]Koopmanschap M, Burdorf A, Jacob K, Meerding WJ, Brouwer W, Severens H: Measuring productivity changes in economic evaluation: setting the research agenda. PharmacoEconomics 2005, 23(1):47-54.
• [92]Barnett PG, Wong W, Hall S: The cost-effectiveness of a smoking cessation program for out-patients in treatment for depression. Addiction 2008, 103(5):834-840.
• [93]Turner DA, Paul S, Stone MA, Juarez-Garcia A, Squire I, Khunti K: Cost-effectiveness of a disease management programme for secondary prevention of coronary heart disease and heart failure in primary care. Heart (British Cardiac Society) 2008, 94(12):1601-1606.
• [94]Gerhards SA, de Graaf LE, Jacobs LE, Severens JL, Huibers MJ, Arntz A, Riper H, Widdershoven G, Metsemakers JF, Evers SM: Economic evaluation of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial. Brit J Psychiat 2010, 196(4):310-318.
• [95]Heatherton TF, Kozlowski LT, Frecker RC, Fagerstroem KO: The fagerstroem test for nicotine dependence: a revision of the fagerstroem tolerance questionnaire. Br J Addict 1991, 86(9):1119-1127.
• [96]Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiat Scand 1983, 67(6):361-370.
• [97]Denollet J: DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005, 67(1):89-97.
• [98]Dijkstra A, De Vries H, Bakker M: Pros and cons of quitting, self-efficacy, and the stages of change in smoking cessation. J Consult Clin Psych 1996, 64(4):758-763.
• [99]De Vries H, Mudde A, Leijs I, Charlton A, Vartiainen E, Buijs G, Clemente MP, Storm H, Gonzalez Navarro A, Nebot M, et al.: The European Smoking Prevention Framework Approach (EFSA): an example of integral prevention. Health Educ Res 2003, 18(5):611-626.
• [100]Fishbein M, Ajzen I: Predicting and Changing Behavior: The Reasoned Action Approach. 2010.
• [101]De Vries H, Mesters I, Van der Steeg H, Honing C: The general public’s information needs and perceptions regarding hereditary cancer: an application of the integrated change model. Patient Educ Couns 2005, 56:154-165.
• [102]Maas CJM, Hox JJ: Sufficient sample sizes for multilevel modeling. Methodology 2005, 1(3):86-92.
• [103]McCarty MC, Hennrikus DJ, Lando HA, Vessey JT: Nurses’ attitudes concerning the delivery of brief cessation advice to hospitalized smokers. Prev Med 2001, 33(6):674-681.
• [104]McCarty MC, Zander KM, Hennrikus DJ, Lando HA: Barriers among nurses to providing smoking cessation advice to hospitalized smokers. Am J Health Promot 2001, 16(2):85-87. ii..
• [105]Sarna L, Wewers ME, Brown JK, Lillington L, Brecht ML: Barriers to tobacco cessation in clinical practice: report from a National Survey of Oncology Nurses. Nurs Outlook 2001, 49(4):166-172.